Tyler-Stone Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-130
Closed -$10K 399
2024
Q2
$10K Hold
130
﹤0.01% 656
2024
Q1
$8.9K Hold
130
﹤0.01% 672
2023
Q4
$7.51K Hold
130
﹤0.01% 677
2023
Q3
$7K Hold
130
﹤0.01% 660
2023
Q2
$7K Buy
+130
New +$6.79K ﹤0.01% 661
2022
Q4
$6K Hold
130
﹤0.01% 630
2022
Q3
$5K Hold
130
﹤0.01% 631
2022
Q2
$5K Hold
130
﹤0.01% 660
2022
Q1
$6K Sell
130
-37
-22% -$1.6K ﹤0.01% 641
2021
Q4
$7K Buy
+167
New +$7.02K ﹤0.01% 651

Other funds holding BSX

Tyler-Stone Wealth Management's BSX Position: Q3 2024 in Review

Tyler-Stone Wealth Management sold out of Boston Scientific (BSX) in Q3 2024, closing a stake of 130 shares — an estimated $10K sold.

Tyler-Stone Wealth Management first reported a position in BSX in Q4 2021 and held it in 10 quarters. The position peaked at $10K in Q2 2024. 1,395 funds tracked by Wall St. Rank hold BSX as of Q3 2024.

  • Tyler-Stone Wealth Management reported no remaining Boston Scientific position as of Q3 2024 after selling out during the quarter.
  • Tyler-Stone Wealth Management sold 130 Boston Scientific shares in Q3 2024, an estimated $10K.
  • Tyler-Stone Wealth Management first reported a position in Boston Scientific in Q4 2021 and held it in 10 quarters.
  • Tyler-Stone Wealth Management's Boston Scientific position peaked at $10K in Q2 2024.
  • 1,395 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2024.

Based on Tyler-Stone Wealth Management's 13F filing for Q3 2024, filed 4 Nov 2024.